Here are five cases of companies tied up in device and drug patent litigation since the beginning of 2025: 1. NuVasive infringed five patents from a spine surgeon, a jury determined in April. The jury ...

You could earn truly passive income with these investments. Find out how much you'll make in a single year, depending on how ...

In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability.

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...